Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA LUPIN ASTRAZENECA PHARMA/
LUPIN
 
P/E (TTM) x 97.6 41.2 237.1% View Chart
P/BV x 23.2 6.1 383.5% View Chart
Dividend Yield % 0.3 0.2 120.3%  

Financials

 ASTRAZENECA PHARMA   LUPIN
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
LUPIN
Mar-23
ASTRAZENECA PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs3,620799 453.1%   
Low Rs2,438583 418.1%   
Sales per share (Unadj.) Rs401.2365.8 109.7%  
Earnings per share (Unadj.) Rs39.79.8 403.6%  
Cash flow per share (Unadj.) Rs46.229.2 158.3%  
Dividends per share (Unadj.) Rs16.004.00 400.0%  
Avg Dividend yield %0.50.6 91.3%  
Book value per share (Unadj.) Rs234.4270.7 86.6%  
Shares outstanding (eoy) m25.00454.98 5.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.51.9 399.6%   
Avg P/E ratio x76.370.2 108.6%  
P/CF ratio (eoy) x65.523.7 276.9%  
Price / Book Value ratio x12.92.6 506.1%  
Dividend payout %40.340.7 99.1%   
Avg Mkt Cap Rs m75,718314,381 24.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,59130,872 8.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,030166,417 6.0%  
Other income Rs m2611,509 17.3%   
Total revenues Rs m10,291167,926 6.1%   
Gross profit Rs m1,24917,206 7.3%  
Depreciation Rs m1638,807 1.8%   
Interest Rs m62,743 0.2%   
Profit before tax Rs m1,3417,165 18.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3482,688 13.0%   
Profit after tax Rs m9934,477 22.2%  
Gross profit margin %12.510.3 120.4%  
Effective tax rate %26.037.5 69.2%   
Net profit margin %9.92.7 368.0%  
BALANCE SHEET DATA
Current assets Rs m9,359124,513 7.5%   
Current liabilities Rs m4,84492,654 5.2%   
Net working cap to sales %45.019.1 235.2%  
Current ratio x1.91.3 143.8%  
Inventory Days Days4926 188.7%  
Debtors Days Days3998 39.8%  
Net fixed assets Rs m2,061103,490 2.0%   
Share capital Rs m50910 5.5%   
"Free" reserves Rs m5,811122,246 4.8%   
Net worth Rs m5,861123,156 4.8%   
Long term debt Rs m0275 0.0%   
Total assets Rs m11,421228,003 5.0%  
Interest coverage x213.93.6 5,920.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.7 120.3%   
Return on assets %8.73.2 276.3%  
Return on equity %16.93.6 466.0%  
Return on capital %23.08.0 286.4%  
Exports to sales %00-   
Imports to sales %37.40-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m3,747NA-   
Fx inflow Rs m61248,057 1.3%   
Fx outflow Rs m3,74721,752 17.2%   
Net fx Rs m-3,13526,306 -11.9%   
CASH FLOW
From Operations Rs m58318,972 3.1%  
From Investments Rs m181-12,868 -1.4%  
From Financial Activity Rs m-245-3,373 7.3%  
Net Cashflow Rs m5192,732 19.0%  

Share Holding

Indian Promoters % 0.0 46.8 -  
Foreign collaborators % 75.0 0.3 26,785.7%  
Indian inst/Mut Fund % 5.4 45.8 11.8%  
FIIs % 2.7 16.1 16.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 53.0 47.2%  
Shareholders   29,032 281,542 10.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Lupin Share Price Performance

Period ASTRAZENECA PHARMA Lupin S&P BSE HEALTHCARE
1-Day -0.17% 0.65% 0.79%
1-Month -15.59% 8.82% 3.52%
1-Year 60.07% 147.91% 61.40%
3-Year CAGR 16.16% 15.75% 17.85%
5-Year CAGR 21.38% 15.82% 20.06%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex, Nifty Hit Fresh Record High | Metal Stocks Shine in Special Trading Session | Tata Steel, SAIL, JSW Steel Up 3% Sensex, Nifty Hit Fresh Record High | Metal Stocks Shine in Special Trading Session | Tata Steel, SAIL, JSW Steel Up 3%(Closing)

Indian share markets traded marginally higher throughout the special trading sessions today and ended on a positive note.